Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

NCT ID: NCT00097799

Last Updated: 2016-11-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

APPROVED_FOR_MARKETING

Study Classification

EXPANDED_ACCESS

Study Start Date

2004-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tipranavir

500 mg twice daily

Intervention Type DRUG

Ritonavir

200 mg twice daily

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Eligible Sex

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

1182.70.127 Health Services Center, Inc.

Anniston, Alabama, United States

Site Status

1182.70.006 Spectrum Medical Group

Phoenix, Arizona, United States

Site Status

1182.70.016 Health for Life Clinic

Little Rock, Arkansas, United States

Site Status

1182.70.065

Anaheim, California, United States

Site Status

1182.70.246

Baldwin Park, California, United States

Site Status

1182.70.043

Fountain Valley, California, United States

Site Status

1182.70.092

Fresno, California, United States

Site Status

1182.70.057

Glendale, California, United States

Site Status

1182.70.064

Harbor City, California, United States

Site Status

1182.70.079

Long Beach, California, United States

Site Status

1182.70.015

Los Angeles, California, United States

Site Status

1182.70.053

Los Angeles, California, United States

Site Status

1182.70.066

Los Angeles, California, United States

Site Status

1182.70.071

Los Angeles, California, United States

Site Status

1182.70.137

Los Angeles, California, United States

Site Status

1182.70.198

Los Angeles, California, United States

Site Status

1182.70.008

Newport Beach, California, United States

Site Status

1182.70.081

Oakland, California, United States

Site Status

1182.70.095

Oakland, California, United States

Site Status

1182.70.067

Panorama City, California, United States

Site Status

1182.70.033

San Diego, California, United States

Site Status

1182.70.014

San Francisco, California, United States

Site Status

1182.70.020

San Francisco, California, United States

Site Status

1182.70.048

San Francisco, California, United States

Site Status

1182.70.085

San Francisco, California, United States

Site Status

1182.70.214

San Francisco, California, United States

Site Status

1182.70.022

San Rafael, California, United States

Site Status

1182.70.222

Stanford, California, United States

Site Status

1182.70.005

Tarzana, California, United States

Site Status

1182.70.030

Tarzana, California, United States

Site Status

1182.70.068

Woodland Hills, California, United States

Site Status

1182.70.218 Denver Infectious Disease Consultants

Denver, Colorado, United States

Site Status

1182.70.281

Denver, Colorado, United States

Site Status

1182.70.074

New Haven, Connecticut, United States

Site Status

1182.70.073

Norwich, Connecticut, United States

Site Status

1182.70.032

Washington D.C., District of Columbia, United States

Site Status

1182.70.042

Washington D.C., District of Columbia, United States

Site Status

1182.70.289 Dupont Circle Physicians Group

Washington D.C., District of Columbia, United States

Site Status

1182.70.003

Fort Lauderdale, Florida, United States

Site Status

1182.70.013

Fort Lauderdale, Florida, United States

Site Status

1182.70.049

Fort Lauderdale, Florida, United States

Site Status

1182.70.096

Fort Lauderdale, Florida, United States

Site Status

1182.70.045

Fort Myers, Florida, United States

Site Status

1182.70.026

Hollywood, Florida, United States

Site Status

1182.70.023

Miami, Florida, United States

Site Status

1182.70.040

North Palm Beach, Florida, United States

Site Status

1182.70.007

Orlando, Florida, United States

Site Status

1182.70.117

Plantation, Florida, United States

Site Status

1182.70.017

Pompano Beach, Florida, United States

Site Status

1182.70.047

West Palm Beach, Florida, United States

Site Status

1182.70.002

Atlanta, Georgia, United States

Site Status

1182.70.046

Atlanta, Georgia, United States

Site Status

1182.70.069

Atlanta, Georgia, United States

Site Status

1182.70.037

Dactur, Georgia, United States

Site Status

1182.70.058

Jesup, Georgia, United States

Site Status

1182.70.174

Macon, Georgia, United States

Site Status

1182.70.019

Chicago, Illinois, United States

Site Status

1182.70.029 Dr. David Moore

Chicago, Illinois, United States

Site Status

1182.70.194

Chicago, Illinois, United States

Site Status

1182.70.010

Joliet, Illinois, United States

Site Status

1182.70.167

Indianapolis, Indiana, United States

Site Status

1182.70.192

Iowa City, Iowa, United States

Site Status

1182.70.099

New Orleans, Louisiana, United States

Site Status

1182.70.025 Chase Brexton Health Services, Inc

Baltimore, Maryland, United States

Site Status

1182.70.082

Boston, Massachusetts, United States

Site Status

1182.70.090

Boston, Massachusetts, United States

Site Status

1182.70.004

Berkley, Michigan, United States

Site Status

1182.70.084

Detroit, Michigan, United States

Site Status

1182.70.035

St Louis, Missouri, United States

Site Status

1182.70.242

St Louis, Missouri, United States

Site Status

1182.70.093

Lincoln, Nebraska, United States

Site Status

1182.70.021

Las Vegas, Nevada, United States

Site Status

1182.70.288 Hackensack University Medical Center

Hackensack, New Jersey, United States

Site Status

1182.70.075

Sommers Point, New Jersey, United States

Site Status

1182.70.024

Briarcliff Manor, New York, United States

Site Status

1182.70.105

Bronk, New York, United States

Site Status

1182.70.039

Kingston, New York, United States

Site Status

1182.70.028

New York, New York, United States

Site Status

1182.70.031

New York, New York, United States

Site Status

1182.70.036

New York, New York, United States

Site Status

1182.70.050

New York, New York, United States

Site Status

1182.70.062

New York, New York, United States

Site Status

1182.70.104

New York, New York, United States

Site Status

1182.70.086 Boehringer Ingelheim Investigational Site

Rochester, New York, United States

Site Status

1182.70.250 Montefiore Medical Center

The Bronx, New York, United States

Site Status

1182.70.061

Asheville, North Carolina, United States

Site Status

1182.70.100

Chapel Hill, North Carolina, United States

Site Status

1182.70.136 Mecklenburg Medical Group, P.A.

Charlotte, North Carolina, United States

Site Status

1182.70.103

Durham, North Carolina, United States

Site Status

1182.70.241 University of CIncinnati Medical Center

Cincinnati, Ohio, United States

Site Status

1182.70.044

Portland, Oregon, United States

Site Status

1182.70.059 Fanno Creek Clinic

Portland, Oregon, United States

Site Status

1182.70.077 Kaiser Permanente-IDC

Portland, Oregon, United States

Site Status

1182.70.051

Philadelphia, Pennsylvania, United States

Site Status

1182.70.080

Philadelphia, Pennsylvania, United States

Site Status

1182.70.072

Providence, Rhode Island, United States

Site Status

1182.70.126

Charleston, South Carolina, United States

Site Status

1182.70.271

Charleston, South Carolina, United States

Site Status

1182.70.088

Columbia, South Carolina, United States

Site Status

1182.70.165 Comprehensive Care Center

Nashville, Tennessee, United States

Site Status

1182.70.018

Austin, Texas, United States

Site Status

1182.70.038

Dallas, Texas, United States

Site Status

1182.70.041

Dallas, Texas, United States

Site Status

1182.70.055

Dallas, Texas, United States

Site Status

1182.70.070

Dallas, Texas, United States

Site Status

1182.70.060

El Paso, Texas, United States

Site Status

1182.70.052

Houston, Texas, United States

Site Status

1182.70.054

Houston, Texas, United States

Site Status

1182.70.285

Houston, Texas, United States

Site Status

1182.70.128 Olmos Park Medical Associates

San Antonio, Texas, United States

Site Status

1182.70.011

Annadale, Virginia, United States

Site Status

1182.70.217

Richmond, Virginia, United States

Site Status

1182.70.097

Seattle, Washington, United States

Site Status

1182.70.76

Seattle, Washington, United States

Site Status

1182.70.083

Spokane, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Puerto Rico United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1182.70

Identifier Type: -

Identifier Source: org_study_id